These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24846552)

  • 1. Left atrial thrombus after complete left atrial appendage exclusion with LARIAT device.
    Koranne KP; Fernando RR; Laing ST
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):E54-7. PubMed ID: 24846552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial thrombus after appendage closure using LARIAT.
    Giedrimas E; Lin AC; Knight BP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):e52-3. PubMed ID: 23962862
    [No Abstract]   [Full Text] [Related]  

  • 3. Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second-generation Amplatzer Cardiac Plug (Amulet device).
    Lam SC; Bertog S; Sievert H
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):321-7. PubMed ID: 24550125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombus formation after left atrial appendage exclusion using an Amplatzer cardiac plug device.
    Cruz-Gonzalez I; Martín Moreiras J; García E
    Catheter Cardiovasc Interv; 2011 Nov; 78(6):970-3. PubMed ID: 21523900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
    Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Fibrillation in Heart Failure: Left Atrial Appendage Management.
    Ellis CR; Kanagasundram AN
    Cardiol Clin; 2019 May; 37(2):241-249. PubMed ID: 30926025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
    J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke.
    Mosley WJ; Smith MR; Price MJ
    Catheter Cardiovasc Interv; 2014 Mar; 83(4):664-9. PubMed ID: 24214652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation.
    Stone D; Byrne T; Pershad A
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):121-7. PubMed ID: 23765504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Experience of Transcatheter Leak Occlusion With Detachable Coils Following Left Atrial Appendage Closure.
    Della Rocca DG; Horton RP; Di Biase L; Bassiouny M; Al-Ahmad A; Mohanty S; Gasperetti A; Natale VN; Trivedi C; Gianni C; Burkhardt JD; Gallinghouse GJ; Hranitzky P; Sanchez JE; Natale A
    JACC Cardiovasc Interv; 2020 Feb; 13(3):306-319. PubMed ID: 31954677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Implications of Leaks Following Left Atrial Appendage Ligation With the LARIAT Device.
    Gianni C; Di Biase L; Trivedi C; Mohanty S; Gökoğlan Y; Güneş MF; Bai R; Al-Ahmad A; Burkhardt JD; Horton RP; Krumerman AK; Palma EC; Valderrábano M; Gibson D; Price MJ; Natale A
    JACC Cardiovasc Interv; 2016 May; 9(10):1051-7. PubMed ID: 27198686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Left Atrial Appendage Dimensions Following Volume Loading During Percutaneous Left Atrial Appendage Closure.
    Spencer RJ; DeJong P; Fahmy P; Lempereur M; Tsang MYC; Gin KG; Lee PK; Nair P; Tsang TSM; Jue J; Saw J
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1935-1941. PubMed ID: 26738661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term safety and efficacy of left atrial appendage closure with the WATCHMAN device in patients with small left atrial appendage ostia.
    Venkataraman G; Strickberger SA; Doshi S; Ellis CR; Lakkireddy D; Whalen SP; Cuoco F
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):17-21. PubMed ID: 28877379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Atrial Appendage Occlusion for Stroke Prevention.
    Chanda A; Reilly JP
    Prog Cardiovasc Dis; 2017; 59(6):626-635. PubMed ID: 28457791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: Long-term results of a multicenter study.
    Mohanty S; Gianni C; Trivedi C; Gadiyaram V; Della Rocca DG; MacDonald B; Horton R; Al-Ahmad A; Gibson DN; Price M; Krumerman AK; Palma EC; Di Biase L; Lakkireddy D; Natale A
    Heart Rhythm; 2020 Feb; 17(2):175-181. PubMed ID: 31400519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.